Stroke, as a devastating disease of huge and increasing medical and socio-economic significance, can be called a disease of the 21st century. Almost unheard of as a public health problem before the 19th century and the first three quarters of the 20th century, it is now the second leading cause of death and disability worldwide. From 2005 onwards (Figure 1) , stroke prevalence has been increasing exponentially and we now have over 104 million people in the world living with stroke aftermath. The resulting disability-adjusted life-years lost have already reached 132 million, which is more than that from lung, breast, cervical, colon/rectum, stomach, and liver cancers combined. If the current trend continues, by 2030 we will have over 154 million stroke survivors and almost 10 million people dying from stroke every year. Moreover, with over 60% of stroke burden occurring in people younger than 70 years, stroke is no longer a disease of the elderly, and we are witnessing an ominous trend towards increasing stroke incidence and mortality rates in young adults and children in many countries.
This clearly indicates that the currently used primary stroke prevention strategies are either not sufficiently effective or not used widely enough, or both. Of particular concern is the shift of public health efforts from implementation of proven effective population-wide preventative strategies to high absolute cardiovascular disease (CVD) risk strategies observed in several high-income countries. It was estimated that those high CVD strategies can at best only reduce the CVD incidence by about 11%, while there is overwhelming evidence from large randomized clinical trials and meta-analyses that just screening of the population for high absolute CVD risk, even when associated with some counseling, is not effective. There is also evidence of the low value of routinely available stroke prevention educational materials, such as books, brochures, leaflets, and websites.
It is imperative that primary stroke prevention should be based on both population-wide and individual preventative strategies, with priority given to the reduction of exposure to CVD risk factors for the whole population across the life course. The focus of preventative interventions should be on the reduction of blood pressure level in the whole population, control of elevated blood pressure on the individual level, as well as improving behavioral and lifestyle risk factors profile on both individual and population levels, including reduction of exposure to tobacco use, unhealthy diet (excessive salt and sugar intake, lack of fruits and vegetables), physical inactivity, and the harmful use of alcohol.
To be effective, primary stroke prevention strategies at the individual level should be provided for all people at risk regardless of the level of stroke or CVD risk; it needs to be motivational, engaging (interactive), simple to use and understand, widely available across the globe, free of charge, specific for the individual concerned, and based on valid (ideally, culturally specific) information (including internationally recognized guidelines on primary stroke and CVD prevention). To date, the only tool that meets all these requirements is the validated Stroke Riskometer app developed and owned by the Auckland University of Technology (New Zealand), translated into 15 languages (>90% of the world population) and endorsed by the World Stroke Organization, World Federation of Neurology, World Heart Federation, and European Stroke Organisation. Widely recognized as a new paradigm in primary stroke prevention (so-called ''motivational population-wide stroke prevention strategy''), the app can be downloaded for free to a smartphone, iPad, or Android tablet from Apple Store or Google Play. The far-reaching impact of the app for primary stroke prevention on the individual level could be greatly enhanced by the use of a single-pill combination of antihypertensive medications for management of elevated blood pressure, recently included in the World Health Organization (WHO) list of essential medicines, as well as the involvement of community health workers in the management of lifestyle risk factors.
It was estimated that the wide use of the Stroke Riskometer for lifestyle modification could help to prevent about half a million strokes every year, and just 1 mmHg population-wide reduction in systolic blood pressure could help to avoid an additional 1.6 million strokes in the world. A combination of affordable blood pressure and lipid-lowering medications in one low-cost pill (polypill), along with lifestyle modification via the Stroke Riskometer app and community health workers and population-wide preventative strategies, is a conceptual approach of the WHO to primary stroke prevention. As stroke shares many risk factors with other major noncommunicable diseases, such as ischemic heart disease, diabetes mellitus, vascular dementia, and some types of cancer, it is likely that the wide use of the Stroke Riskometer by adults and the implementation of the app-associated software and recommendations into the electronic patient management/information systems by health professionals will not only save millions of lives but also billions of dollars of tax-payer money across the globe. At the 1st Ministerial Stroke meeting of Latin American countries in August 2018, the app was recommended for implementation across all Latin American countries. To facilitate this important improvement in primary stroke prevention on the global level, the World Stroke Organization will leverage the Stroke Riskometer app for its 2019 stroke awareness campaign.
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